IWM
GILD icon

IHT Wealth Management’s Gilead Sciences GILD Stock Holding History

IHT Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.03M Buy
31,870
+2,545
+9% +$335K 0.09% 248
2026
Q1 		$4.09M Buy
29,325
+13,307
+83% +$1.86M 0.1% 218
2025
Q4 		$1.97M Buy
16,018
+3,783
+31% +$460K 0.05% 345
2025
Q3 		$1.36M Buy
12,235
+177
+1% +$20.1K 0.03% 443
2025
Q2 		$1.34M Sell
12,058
-60
-0.5% -$6.38K 0.04% 425
2025
Q1 		$1.36M Buy
12,118
+390
+3% +$40.2K 0.04% 387
2024
Q4 		$1.08M Sell
11,728
-1,418
-11% -$128K 0.04% 433
2024
Q3 		$1.1M Buy
13,146
+319
+2% +$24.3K 0.03% 475
2024
Q2 		$882K Sell
12,827
-1,618
-11% -$108K 0.03% 465
2024
Q1 		$1.06M Buy
14,445
+278
+2% +$21.4K 0.04% 405
2023
Q4 		$1.15M Buy
14,167
+71
+0.5% +$5.53K 0.05% 351
2023
Q3 		$1.06M Sell
14,096
-58
-0.4% -$4.46K 0.05% 336
2023
Q2 		$1.09M Buy
14,154
+4,732
+50% +$377K 0.06% 320
2023
Q1 		$782K Sell
9,422
-153
-2% -$12.7K 0.04% 366
2022
Q4 		$822K Buy
9,575
+316
+3% +$25K 0.05% 346
2022
Q3 		$571K Buy
9,259
+1,967
+27% +$124K 0.04% 419
2022
Q2 		$451K Buy
7,292
+8
+0.1% +$495 0.04% 408
2022
Q1 		$433K Buy
7,284
+266
+4% +$17K 0.03% 449
2021
Q4 		$510K Buy
7,018
+24
+0.3% +$1.65K 0.04% 431
2021
Q3 		$489K Sell
6,994
-9,057
-56% -$636K 0.04% 435
2021
Q2 		$1.1M Buy
16,051
+7,329
+84% +$489K 0.07% 300
2021
Q1 		$564K Sell
8,722
-740
-8% -$47.7K 0.04% 415
2020
Q4 		$551K Sell
9,462
-680
-7% -$41K 0.05% 374
2020
Q3 		$641K Buy
10,142
+1,442
+17% +$100K 0.06% 284
2020
Q2 		$669K Sell
8,700
-4,866
-36% -$373K 0.09% 231
2020
Q1 		$1.01M Sell
13,566
-1,688
-11% -$117K 0.15% 160
2019
Q4 		$991K Sell
15,254
-2,995
-16% -$195K 0.12% 198
2019
Q3 		$1.16M Buy
18,249
+3,650
+25% +$239K 0.16% 151
2019
Q2 		$986K Sell
14,599
-1,371
-9% -$90.2K 0.14% 158
2019
Q1 		$1.04M Sell
15,970
-2,839
-15% -$189K 0.17% 143
2018
Q4 		$1.18M Buy
18,809
+54
+0.3% +$3.77K 0.23% 114
2018
Q3 		$1.45M Buy
18,755
+235
+1% +$17.7K 0.31% 86
2018
Q2 		$1.31M Buy
18,520
+146
+0.8% +$10.3K 0.34% 76
2018
Q1 		$1.34M Sell
18,374
-2,444
-12% -$194K 0.36% 57
2017
Q4 		$1.55M Buy
20,818
+11,289
+118% +$857K 0.41% 50
2017
Q3 		$781K Buy
9,529
+942
+11% +$72K 0.33% 76
2017
Q2 		$21 Sell
8,587
-1,552
-15% -$103K 0.01% 770
2017
Q1 		$672K Sell
10,139
-499
-5% -$35.1K 0.45% 53
2016
Q4 		$789K Buy
+10,638
New +$791K 0.6% 32

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IHT Wealth Management's GILD Position: Q2 2026 in Review

IHT Wealth Management increased its Gilead Sciences (GILD) stake by 8.7% in Q2 2026, buying an estimated $335K and bringing the position to 31,870 shares worth $4.03M. The position accounts for 0.09% of the portfolio, ranked #248.

IHT Wealth Management first reported a position in GILD in Q4 2016 and has held it in 39 quarters since. The position peaked at $4.09M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • IHT Wealth Management held 31,870 shares of Gilead Sciences worth $4.03M as of Q2 2026.
  • IHT Wealth Management bought 2,545 Gilead Sciences shares in Q2 2026, an estimated $335K.
  • Gilead Sciences made up 0.09% of IHT Wealth Management's portfolio in Q2 2026, its #248 holding.
  • IHT Wealth Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 39 quarters since.
  • IHT Wealth Management's Gilead Sciences position peaked at $4.09M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on IHT Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.